Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen (IMAGE)

Impact Journals LLC

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.